{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:09:57Z","timestamp":1784297397769,"version":"3.55.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK R0146073"],"award-info":[{"award-number":["DK R0146073"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK081943"],"award-info":[{"award-number":["P30 DK081943"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["K08-DK088944"],"award-info":[{"award-number":["K08-DK088944"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nephcure-ASN Foundation"},{"name":"Robert Kelsch Collegiate Professorship"},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08-DK106523-01."],"award-info":[{"award-number":["K08-DK106523-01."]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155255","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T17:39:33Z","timestamp":1463593173000},"page":"e0155255","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Podocyte Depletion in Thin GBM and Alport Syndrome"],"prefix":"10.1371","volume":"11","author":[{"given":"Larysa","family":"Wickman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Hodgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Q.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farsad","family":"Afshinnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kershaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger C.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1097\/01.ASN.0000141462.00630.76","article-title":"The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family","volume":"15","author":"BG Hudson","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1093\/ndt\/gft253","article-title":"Molecular genetics of familial hematuric diseases","volume":"28","author":"C Deltas","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrneph.2012.259","article-title":"Alport syndrome\u2013insights from basic and clinical research","volume":"9","author":"J Kruegel","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.semnephrol.2012.06.005","article-title":"Role of the podocyte (and glomerular endothelium) in building the GBM","volume":"32","author":"DR Abrahamson","year":"2012","journal-title":"Semin Nephrol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.5858\/2006-130-699-TGBMNI","article-title":"Thin Glomerular basement Membrane nephropathy. Incidence in 3471 consecutive renal biopsies examined by electron kicroscopy","volume":"130","author":"M Haas","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X- linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study","volume":"14","author":"JP Jais","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5858\/133.2.224","article-title":"Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis","volume":"133","author":"M Haas","year":"2009","journal-title":"Arch pathol Lab Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00467-012-2356-9","article-title":"The renal biopsy in the genomic era","volume":"28","author":"H Liapis","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1093\/ndt\/gfp158","article-title":"Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3\/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis","volume":"24","author":"A Pierides","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1681\/ASN.2007040444","article-title":"COL4A3\/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy","volume":"18","author":"K Voskarides","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref11","first-page":"1253","article-title":"Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis","volume":"86","author":"A Malone","year":"2014"},{"key":"ref12","article-title":"Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis","author":"C Gast","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000435789","article-title":"Carriers of autosomal recessive Alport Syndrome with thin GBM nephropathy presenting as focal segmental glomerulosclerosis in later life","volume":"130","author":"C Deltas","year":"2015","journal-title":"Nephron"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","article-title":"The spectrum of podocytopathies: A unifying view of glomerular diseases","volume":"71","author":"R Wiggins","year":"2007","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1523-1755.1998.00044.x","article-title":"Progression of glomerular diseases: is the podocyte the culprit?","volume":"56","author":"W Kriz","year":"1998","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1523-1755.2005.67097.x","article-title":"Pathways to nephron loss starting from glomerular diseases-insights from animal models","volume":"67","author":"W Kriz","year":"2005","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MNH.0b013e3280c8eed3","article-title":"New insights into structural patterns encountered in glomerulosclerosis","volume":"16","author":"M LeHir","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1523-1755.2001.060003957.x","article-title":"Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat","volume":"60","author":"YH Kim","year":"2001","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1681\/ASN.2005010055","article-title":"Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene","volume":"16","author":"BL Wharram","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome","volume":"26","author":"CE Sadowski","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1172\/JCI119163","article-title":"Podocyte loss and progressive glomerular injury in type II diabetes","volume":"99","author":"ME Pagtalunan","year":"1997","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1046\/j.1523-1755.2001.00725.x","article-title":"Basgen JM: International Diabetic Nephropathy Study Group: Glomerular cell number in normal subjects and type I diabetes patients","volume":"59","author":"MW Steffes","year":"2001","journal-title":"Kidney Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2337\/diabetes.51.10.3083","article-title":"European Study for the Prevention of Renal Disease in Type I diabetes (ESPRIT): Podocyte number in normotensive type I diabetic patients with albuminuria","volume":"51","author":"KE White","year":"2002","journal-title":"Diabetes"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1046\/j.1523-1755.2002.00269.x","article-title":"Myers BD: Podocytopenia and disease severity in IgA nephropathy","volume":"61","author":"KV Lemley","year":"2002","journal-title":"Kidney Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2337\/diabetes.52.4.1031","article-title":"Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes","volume":"52","author":"M Dalla Vestra","year":"2003","journal-title":"Diabetes"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ajh.2008.360","article-title":"Podocyte loss in human hypertensive nephrosclerosis","volume":"22","author":"G Wang","year":"2009","journal-title":"Am J Hypertens"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1681\/ASN.2014030287","article-title":"The two kidney to one kidney transition and transplant glomerulopathy: A podocyte perspective","volume":"26","author":"Y Yang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2007121328","article-title":"Urine podocyte mRNAs mark progression of renal disease","volume":"20","author":"Y Sato","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ki.2011.306","article-title":"Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease","volume":"81","author":"A Fukuda","year":"2012","journal-title":"Kidney Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1681\/ASN.2012030271","article-title":"Growth-dependent podocyte failure causes glomerulosclerosis","volume":"23","author":"A Fukuda","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1681\/ASN.2013020173","article-title":"Urine podocyte mRNAs, proteinuria and progression in human glomerular diseases","volume":"24","author":"L Wickman","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1681\/ASN.2014080752","article-title":"Kidney aging and Focal Global Glomerulosclerosis. A podometric perspective","volume":"26","author":"J Hodgin","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1681\/ASN.2013080859","article-title":"Estimating podocyte number and density in histologic sections","volume":"25","author":"M Venkatareddy","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1152\/jappl.1962.17.2.343","article-title":"A principle for counting tissue structures on random sections","volume":"17","author":"ER Weibel","year":"1962","journal-title":"J Appl Physiol"},{"key":"ref35","first-page":"40","article-title":"Stereologic Methods: Practical Methods for Biologic Morphometry","author":"ER Weibel","year":"1979"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e3013","DOI":"10.1097\/MD.0000000000003013","article-title":"Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis","volume":"95","author":"WC Tsai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/ki.1996.265","article-title":"The hyperfiltration theory: a paradigm shift in nephrology","volume":"49","author":"BM Brenner","year":"1996","journal-title":"Kidney Int"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1113\/jphysiol.2014.274449","article-title":"Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment","volume":"592","author":"J Savige","year":"2014","journal-title":"J Physiol."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1172\/JCI72267","article-title":"Cellular and molecular mechanisms in kidney fibrosis","volume":"124","author":"JS Duffield","year":"2014","journal-title":"J Clin Invest."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"8","author":"O Gross","year":"2012","journal-title":"Kidney Int"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport Syndrome and Thin Basement Membrane Nephropathy","volume":"24","author":"J Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00467-012-2138-4","article-title":"Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport syndrome research Collaborative","volume":"28","author":"C Kashtan","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.semnephrol.2012.06.009","article-title":"The renin-angiotensin-aldosterone system in podocytes","volume":"32","author":"DO Wenmann","year":"2012","journal-title":"Semin Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T20:59:10Z","timestamp":1656190750000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155255"}},"subtitle":[],"editor":[{"given":"David","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155255","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}